Global Cancer News

FDA Approves Pemazyre (Pemigatinib) for Bile Duct Cancer

The US Food and Drug Administration (FDA) approved the first targeted therapy for bile duct cancer. Pemazyre (pemigatinib) is for adults with advanced bile duct cancer whose cancer has grown after at least one previous chemotherapy treatment and whose tumors…

Read more

FDA Approves Trodelvy (Sacituzumab govitecan-hziy) for Triple Negative Breast Cancer

The US Food and Drug Administration (FDA) approved a new type of therapy for triple-negative breast cancer that has spread to other parts of the body and hasn’t responded to other treatments. Triple-negative breast cancer…

Read more

Common Questions About the New Coronavirus Outbreak

Cancer patients are among those at high-risk of serious illness from an infection because their immune systems are often weakened by cancer and its treatments. Although most people who were treated for cancer in the…

Read more

A combo of fasting plus vitamin C is effective for hard-to-treat cancers, study shows

Researchers have discovered that a fasting-mimicking diet could be more effective at treating some types of cancer when combined with vitamin C. In studies on mice, researchers found that the combination delayed tumor progression in…

Read more

Boosting Dendritic Cells Helps the Immune System Find Pancreatic Cancer

Dendritic cells are part of the immune system’s first line of defense against cancer and infections and is often used in immunotherapy to treat lung cancer. The question in study here is why immunotherapy tends…

Read more